| Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg L Querol, G Nogales-Gadea, R Rojas-Garcia, J Diaz-Manera, J Pardo, ... Neurology 82 (10), 879-886, 2014 | 387 | 2014 |
| Antibodies to contactin‐1 in chronic inflammatory demyelinating polyneuropathy L Querol, G Nogales‐Gadea, R Rojas‐Garcia, E Martinez‐Hernandez, ... Annals of neurology 73 (3), 370-380, 2013 | 379 | 2013 |
| McArdle disease: what do neurologists need to know? A Lucia, G Nogales-Gadea, M Pérez, MA Martín, AL Andreu, J Arenas Nature clinical practice Neurology 4 (10), 568-577, 2008 | 217 | 2008 |
| Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registry A Lucia, JR Ruiz, A Santalla, G Nogales-Gadea, JC Rubio, ... Journal of Neurology, Neurosurgery & Psychiatry 83 (3), 322-328, 2012 | 174 | 2012 |
| Delivery is key: lessons learnt from developing splice‐switching antisense therapies C Godfrey, LR Desviat, B Smedsrød, F Piétri‐Rouxel, MA Denti, P Disterer, ... EMBO molecular medicine 9 (5), 545-557, 2017 | 171 | 2017 |
| Specific contactin N-glycans are implicated in neurofascin binding and autoimmune targeting in peripheral neuropathies M Labasque, B Hivert, G Nogales-Gadea, L Querol, I Illa, ... Journal of Biological Chemistry 289 (11), 7907-7918, 2014 | 128 | 2014 |
| Altered RIG‐I/DDX58‐mediated innate immunity in dermatomyositis X Suárez‐Calvet, E Gallardo, G Nogales‐Gadea, L Querol, M Navas, ... The Journal of pathology 233 (3), 258-268, 2014 | 119 | 2014 |
| Favorable responses to acute and chronic exercise in McArdle patients JL Maté-Munoz, M Moran, M Pérez, C Chamorro-Vina, F Gómez-Gallego, ... Clinical Journal of Sport Medicine 17 (4), 297-303, 2007 | 117 | 2007 |
| An overview of alternative splicing defects implicated in myotonic dystrophy type I A López-Martínez, P Soblechero-Martín, L de-la-Puente-Ovejero, ... Genes 11 (9), 1109, 2020 | 112 | 2020 |
| McArdle Disease: Update of Reported Mutations and Polymorphisms in the PYGM Gene G Nogales‐Gadea, A Brull, A Santalla, AL Andreu, J Arenas, MA Martín, ... Human mutation 36 (7), 669-678, 2015 | 100 | 2015 |
| Niemann-Pick disease treatment: a systematic review of clinical trials A Santos-Lozano, DV García, F Sanchis-Gomar, C Fiuza-Luces, ... Annals of translational medicine 3 (22), 360, 2015 | 87 | 2015 |
| Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy L Querol, AM Siles, R Alba-Rovira, A Jáuregui, J Devaux, ... Scientific reports 7 (1), 14411, 2017 | 84 | 2017 |
| Genotypic and phenotypic features of all Spanish patients with McArdle disease: a 2016 update A Santalla, G Nogales-Gadea, AB Encinar, I Vieitez, A González-Quintana, ... BMC genomics 18, 39-47, 2017 | 78 | 2017 |
| McArdle disease: molecular genetic update AL Andreu, G Nogales-Gadea, D Cassandrini, J Arenas, C Bruno Acta Myologica 26 (1), 53, 2007 | 68 | 2007 |
| Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease G Nogales-Gadea, T Pinos, A Lucia, J Arenas, Y Camara, A Brull, ... Brain 135 (7), 2048-2057, 2012 | 66 | 2012 |
| A proposed molecular diagnostic flowchart for myophosphorylase deficiency (McArdle disease) in blood samples from Spanish patients JC Rubio, I Garcia‐Consuegra, G Nogales‐Gadea, A Blazquez, ... Human mutation 28 (2), 203-204, 2007 | 66 | 2007 |
| McArdle disease: a unique study model in sports medicine A Santalla, G Nogales-Gadea, N Ørtenblad, A Brull, N De Luna, T Pinós, ... Sports medicine 44, 1531-1544, 2014 | 63 | 2014 |
| Proteasome inhibition with bortezomib depletes plasma cells and specific autoantibody production in primary thymic cell cultures from early-onset myasthenia gravis patients AM Gomez, N Willcox, K Vrolix, J Hummel, G Nogales-Gadea, A Saxena, ... The Journal of Immunology 193 (3), 1055-1063, 2014 | 58 | 2014 |
| Expression of the muscle glycogen phosphorylase gene in patients with McArdle disease: the role of nonsense‐mediated mRNA decay G Nogales‐Gadea, JC Rubio, I Fernandez‐Cadenas, I Garcia‐Consuegra, ... Human mutation 29 (2), 277-283, 2008 | 58 | 2008 |
| Analysis of serum miRNA profiles of myasthenia gravis patients G Nogales-Gadea, A Ramos-Fransi, X Suarez-Calvet, M Navas, ... PloS one 9 (3), e91927, 2014 | 51 | 2014 |
Miguel A. MartinHospital Universitario 12 de Octubre. Instituto de Investigación i+12Correu electrònic verificat a h12o.es
